Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycine Pour la Vie Des Enfants au Niger - Implémentation et Recherche: Essai mortalité et résistance (Azithromycin for Child Survival in Niger: Programmatic Trial)

NCT05288023 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05288023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05288023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycine Pour la Vie Des Enfants au Niger - Implémentation et Recherche: Essai mortalité et résistance (Azithromycin for Child Survival in Niger: Programmatic Trial)
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Terminated
Start date
December 1, 2022
Completion date
January 15, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child health, implementation, morality, resistance bacterial